Related references
Note: Only part of the references are listed.Individual risk assessment for prenatal counseling in early-onset growth-restricted and small-for-gestational-age fetuses
Manel Mendoza et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2021)
FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction
Nir Melamed et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)
sFlt-1/PlGF ratio and timing of delivery in early-onset fetal growth restriction with antegrade umbilical artery flow
M. S. Quezada et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2020)
Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio
A. Ciobanu et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2019)
Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1/PlGF Ratio in Singleton Pregnancies
Ignacio Herraiz et al.
FETAL DIAGNOSIS AND THERAPY (2018)
Preeclampsia and the cardiovascular system: An update
Helen Perry et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2018)
Pre-eclampsia and the cardiovascular-placental axis
B. Thilaganathan
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Fetal Medicine Foundation fetal and neonatal population weight charts
K. H. Nicolaides et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice
Mark A. Brown et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2018)
Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study
Francesca Gaccioli et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction
Sakiko Nanjo et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2017)
Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models
Shakila Thangaratinam et al.
BMC MEDICINE (2017)
An integrated approach to fetal growth restriction
Francesc Figueras et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
Angiogenic Factors and Doppler Evaluation in Normally Growing Fetuses at Routine Third-Trimester Scan: Prediction of Subsequent Low Birth Weight
Stefania Triunfo et al.
FETAL DIAGNOSIS AND THERAPY (2016)
The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia
Tinnakorn Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2016)
Italian Advisory Board: sFlt-1/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management
Daniela Di Martino et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2016)
The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure?
Laura A. Magee et al.
HYPERTENSION (2016)
A Common Profile of Disordered Angiogenic Factor Production and the Exacerbation of Inflammation in Early Preeclampsia, Late Preeclampsia, and Intrauterine Growth Restriction
Sebastian Kwiatkowski et al.
PLOS ONE (2016)
Consensus definition of fetal growth restriction: a Delphi procedure
S. J. Gordijn et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
Christoph C. Lees et al.
LANCET (2015)
Less-Tight versus Tight Control of Hypertension in Pregnancy
Laura A. Magee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Implementation of the sFlt-1/PIGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice
H. Stepan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2015)
Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles
Thushari I. Alahakoon et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2014)
The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction
Katharina Schoofs et al.
JOURNAL OF PERINATAL MEDICINE (2014)
Characterization of the Soluble fms-Like Tyrosine Kinase-1 to Placental Growth Factor Ratio in Pregnancies Complicated by Fetal Growth Restriction
Ignacio Herraiz et al.
OBSTETRICS AND GYNECOLOGY (2014)
Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion
S. Triunfo et al.
PLACENTA (2014)
Treatment of poor placentation and the prevention of associated adverse outcomes - what does the future hold?
R. N. Spencer et al.
PRENATAL DIAGNOSIS (2014)
Stage-based approach to the management of fetal growth restriction
Francesc Figueras et al.
PRENATAL DIAGNOSIS (2014)
Prediction and prevention of ischemic placental disease
Alexander M. Friedman et al.
SEMINARS IN PERINATOLOGY (2014)
Ischemic placental disease: A unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption
Cande V. Ananth
SEMINARS IN PERINATOLOGY (2014)
First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler
F. Crovetto et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2014)
Global and regional estimates of preeclampsia and eclampsia: a systematic review
Edgardo Abalos et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
Stefan Verlohren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia
Stefan Verlohren et al.
CLINICAL SCIENCE (2012)
Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women
Marzena Laskowska et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)
Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction
Jeanne Sibiude et al.
PLOS ONE (2012)
Angiogenic Factors in Maternal Circulation and the Risk of Severe Fetal Growth Restriction
Bjorn Olava Asvold et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
The Great Obstetrical Syndromes are associated with disorders of deep placentation
Ivo Brosens et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Stillbirths 2 Stillbirths: Where? When? Why? How to make the data count?
Joy E. Lawn et al.
LANCET (2011)
Is Fetal Growth Restriction Associated with a More Severe Maternal Phenotype in the Setting of Early Onset Pre-Eclampsia? A Retrospective Study
Jane Weiler et al.
PLoS One (2011)
Cognitive Function After Intrauterine Growth Restriction and Very Preterm Birth
Eva Morsing et al.
PEDIATRICS (2011)
A decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia
Tinnakorn Chaiworapongsa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
Stefan Verlohren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Late Onset Preeclampsia is not an Innocuous Condition
L. Kenneth et al.
HYPERTENSION IN PREGNANCY (2010)
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
Juan Pedro Kusanovic et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2009)
Clinical features of fetal growth restriction complicated later by preeclampsia
Minoru Mitani et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
Predicting Adverse Outcomes in Women with Severe Pre-eclampsia
Peter von Dadelszen et al.
SEMINARS IN PERINATOLOGY (2009)
Early intervention in management of very preterm growth-restricted fetuses: 2-year outcome of infants delivered on fetal indication before 30 gestational weeks
J. Brodszki et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2009)
Angiogene Faktoren und ihre Rolle in der Entstehung und Vorhersage der Präeklampsie
H. Stepan et al.
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE (2009)
Preeclampsia more than 1 disease - Or is it?
James M. Roberts et al.
HYPERTENSION (2008)
Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
Tinnakorn Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age
Offer Erez et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation
Tinnakorn Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
Roberto Romero et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation
O. Gomez et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule
P. Brownbill et al.
ENDOCRINOLOGY (2007)
Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia
E. Ramsey Unal et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction
Holger Stepan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Angiogenic growth factor levels in maternal and fetal blood:: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction
D. Schlembach et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction
Wenzel Wallner et al.
CLINICAL SCIENCE (2007)
Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction
Makrina D. Savvidou et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction
Fatima Crispi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates
Theodora Boutsikou et al.
EARLY HUMAN DEVELOPMENT (2006)
Soluble endoglin contributes to the pathogenesis of preeclampsia
Shivalingappa Venkatesha et al.
NATURE MEDICINE (2006)
An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia
CW Park et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: Relationship to circulating placental growth factor
E Shibata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin
E Bujold et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2005)
Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?
RM Shear et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies
K Duckitt et al.
BRITISH MEDICAL JOURNAL (2005)
Neurologic and developmental disability at six years of age after extremely preterm birth.
N Marlow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
T Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evidence supporting a rote for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia -: Young Investigator Award
T Chaiworapongsa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
What is the best measure of maternal complications of term pregnancy: Ongoing pregnancies or pregnancies delivered?
AB Caughey et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia
K Koga et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences
V Tsatsaris et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies
RN Taylor et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia
SC Tidwell et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Abnormal uterine artery Doppler in small-for-gestational-age pregnancies is associated with later hypertension
LME McCowan et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2001)
Share Paper
